Baillie Gifford & CO Ascendis Pharma A/S Transaction History

Baillie Gifford & CO

$111 Billion
Q1 2025

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$113.0 - $153.43 $5.61 Million - $7.62 Million	-49,668 Reduced 69.89%	21,403 $3.2 Million
Q2 2024 Jul 25, 2024	SELL	$121.07 - $153.67 $1.23 Million - $1.56 Million	-10,135 Reduced 12.48%	71,071 $9.69 Million
Q1 2024 May 01, 2024	SELL	$123.45 - $159.4 $57,280 - $73,961	-464 Reduced 0.57%	81,206 $12.3 Million
Q4 2023 Jan 26, 2024	SELL	$86.1 - $127.36 $400,451 - $592,351	-4,651 Reduced 5.39%	81,670 $10.3 Million
Q3 2023 Nov 13, 2023	SELL	$86.5 - $103.97 $361,656 - $434,698	-4,181 Reduced 4.62%	86,321 $8.08 Million
Q2 2023 Jul 28, 2023	SELL	$69.96 - $97.84 $83,322 - $116,527	-1,191 Reduced 1.3%	90,502 $8.08 Million
Q1 2023 May 03, 2023	BUY	$104.9 - $126.78 $1,153 - $1,394	11 Added 0.01%	91,693 $9.83 Million
Q4 2022 Jan 24, 2023	BUY	$99.42 - $131.97 $316,652 - $420,324	3,185 Added 3.6%	91,682 $11.2 Million
Q3 2022 Oct 27, 2022	BUY	$84.03 - $110.23 $226,628 - $297,290	2,697 Added 3.14%	88,497 $9.14 Million
Q2 2022 Aug 08, 2022	SELL	$78.08 - $117.61 $691,086 - $1.04 Million	-8,851 Reduced 9.35%	85,800 $7.98 Million
Q1 2022 May 05, 2022	BUY	$102.18 - $135.75 $876,602 - $1.16 Million	8,579 Added 9.97%	94,651 $11.1 Million
Q4 2021 Jan 20, 2022	BUY	$127.1 - $169.66 $335,289 - $447,563	2,638 Added 3.16%	86,072 $11.6 Million
Q3 2021 Oct 19, 2021	BUY	$112.67 - $176.92 $1 Million - $1.57 Million	8,882 Added 11.91%	83,434 $13.3 Million
Q2 2021 Aug 02, 2021	SELL	$121.62 - $145.29 $3.37 Million - $4.03 Million	-27,742 Reduced 27.12%	74,552 $9.81 Million
Q1 2021 May 06, 2021	BUY	$124.92 - $173.33 $6.89 Million - $9.56 Million	55,139 Added 116.93%	102,294 $13.2 Million
Q4 2020 Feb 10, 2021	BUY	$151.2 - $182.76 $7.13 Million - $8.62 Million	47,155 New	47,155 $7.87 Million

Others Institutions Holding ASND

# of Institutions

270

Shares Held

61.9M

Call Options Held

151K

Put Options Held

226K

Ra Capital Management, L.P. Boston, MA

10.3M
Shares

$1.67 Billion
33.28% of portfolio
Westfield Capital Management CO LP Boston, MA

5.48M
Shares

$892 Million
4.42% of portfolio
Avoro Capital Advisors LLC New York, NY

5.22M
Shares

$850 Million
13.16% of portfolio
Janus Henderson Group PLC London, X0

4.49M
Shares

$731 Million
0.4% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

4.26M
Shares

$693 Million
1.14% of portfolio

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $9.09B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account